Correlation Between Dupont De and CSPC Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dupont De and CSPC Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and CSPC Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and CSPC Pharmaceutical Group, you can compare the effects of market volatilities on Dupont De and CSPC Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of CSPC Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and CSPC Pharmaceutical.

Diversification Opportunities for Dupont De and CSPC Pharmaceutical

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between Dupont and CSPC is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and CSPC Pharmaceutical Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSPC Pharmaceutical and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with CSPC Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSPC Pharmaceutical has no effect on the direction of Dupont De i.e., Dupont De and CSPC Pharmaceutical go up and down completely randomly.

Pair Corralation between Dupont De and CSPC Pharmaceutical

Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.27 times more return on investment than CSPC Pharmaceutical. However, Dupont De Nemours is 3.73 times less risky than CSPC Pharmaceutical. It trades about 0.05 of its potential returns per unit of risk. CSPC Pharmaceutical Group is currently generating about -0.01 per unit of risk. If you would invest  6,288  in Dupont De Nemours on August 30, 2024 and sell it today you would earn a total of  2,102  from holding Dupont De Nemours or generate 33.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy45.94%
ValuesDaily Returns

Dupont De Nemours  vs.  CSPC Pharmaceutical Group

 Performance 
       Timeline  
Dupont De Nemours 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Dupont De Nemours has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
CSPC Pharmaceutical 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in CSPC Pharmaceutical Group are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, CSPC Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.

Dupont De and CSPC Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dupont De and CSPC Pharmaceutical

The main advantage of trading using opposite Dupont De and CSPC Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, CSPC Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSPC Pharmaceutical will offset losses from the drop in CSPC Pharmaceutical's long position.
The idea behind Dupont De Nemours and CSPC Pharmaceutical Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Valuation
Check real value of public entities based on technical and fundamental data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories